These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25267507

  • 1. MY APPROACH to heart failure with preserved ejection fraction.
    Borlaug BA.
    Trends Cardiovasc Med; 2014 Nov; 24(8):369-70. PubMed ID: 25267507
    [No Abstract] [Full Text] [Related]

  • 2. Ejection fraction is back to normal-now what?
    Chavey WE.
    J Fam Pract; 2010 Mar; 59(3):142-7. PubMed ID: 20230731
    [No Abstract] [Full Text] [Related]

  • 3. Heart Failure with Preserved Ejection Fraction.
    Gladden JD, Chaanine AH, Redfield MM.
    Annu Rev Med; 2018 Jan 29; 69():65-79. PubMed ID: 29414252
    [Abstract] [Full Text] [Related]

  • 4. MY APPROACH to treating heart failure with reduced ejection fraction.
    Greenberg BH.
    Trends Cardiovasc Med; 2014 Nov 29; 24(8):367-8. PubMed ID: 25267506
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Medication adherence in patients with heart failure and a depressed ejection fraction attending cardiology clinics.
    Crespo Leiro MG, Murga N, Matalí A, López-Sendón JL.
    Rev Esp Cardiol; 2009 Apr 29; 62(4):454-5. PubMed ID: 19401134
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?
    Jong P, McKelvie R, Yusuf S.
    BMJ; 2010 Aug 25; 341():c4202. PubMed ID: 20739364
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, Metra M, Lucci D, Gonzini L, Cirrincione V, Montagna L, Di Lenarda A, Maggioni AP, Tavazzi L, IN HF Outcome Investigators.
    Int J Cardiol; 2014 May 01; 173(2):163-9. PubMed ID: 24630337
    [Abstract] [Full Text] [Related]

  • 14. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.
    Eur J Heart Fail; 2015 Apr 01; 17(4):442-52. PubMed ID: 25727879
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J, Ezekowitz JA, Collins SP, Givertz MM, Teerlink JR, Walsh MN, Albert NM, Westlake Canary CA, Carson PE, Colvin-Adams M, Fang JC, Hernandez AF, Hershberger RE, Katz SD, Rogers JG, Spertus JA, Stevenson WG, Sweitzer NK, Tang WH, Stough WG, Starling RC.
    J Card Fail; 2012 Apr 01; 18(4):265-81. PubMed ID: 22464767
    [Abstract] [Full Text] [Related]

  • 18. When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist?
    Bangalore S, Kumar S, Messerli FH.
    Congest Heart Fail; 2013 Apr 01; 19(3):107-15. PubMed ID: 23241032
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.